Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
C4 Therapeutics (CCCC)
NASDAQ:CCCC
C4 Therapeutics (CCCC) Stock Price & Analysis
89 Followers
CCCC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.85 - $13.24
Previous Close$3.08
Volume396.26K
Average Volume (3M)532.78K
Market Cap
$151.12M
Enterprise Value$442.65M
Total Cash (Recent Filing)$49.48M
Total Debt (Recent Filing)$341.01M
Price to Earnings (P/E)-1.1
Beta1.82
Next Earnings
Aug 09, 2023EPS Estimate
-$0.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.68
Shares Outstanding49,063,761
10 Day Avg. Volume598,238
30 Day Avg. Volume532,782
Standard Deviation0.22
R-Squared0.27
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.63
Price to Sales (P/S)40.20
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue18.18
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.89
Forecast
1Y Price Target
$13.83Price Target Upside349.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
C4 Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CCCC FAQ
What was C4 Therapeutics’s price range in the past 12 months?
C4 Therapeutics lowest stock price was $2.85 and its highest was $13.23 in the past 12 months.
What is C4 Therapeutics’s market cap?
Currently, no data Available
When is C4 Therapeutics’s upcoming earnings report date?
C4 Therapeutics’s upcoming earnings report date is Aug 09, 2023 which is in 73 days.
How were C4 Therapeutics’s earnings last quarter?
C4 Therapeutics released its earnings results on May 04, 2023. The company reported -$0.71 earnings per share for the quarter, beating the consensus estimate of -$0.747 by $0.037.
Is C4 Therapeutics overvalued?
According to Wall Street analysts C4 Therapeutics’s price is currently Undervalued.
Does C4 Therapeutics pay dividends?
C4 Therapeutics does not currently pay dividends.
What is C4 Therapeutics’s EPS estimate?
C4 Therapeutics’s EPS estimate is -$0.69.
How many shares outstanding does C4 Therapeutics have?
C4 Therapeutics has 49,063,763 shares outstanding.
What happened to C4 Therapeutics’s price movement after its last earnings report?
C4 Therapeutics reported an EPS of -$0.71 in its last earnings report, beating expectations of -$0.747. Following the earnings report the stock price went up 2.866%.
Which hedge fund is a major shareholder of C4 Therapeutics?
Among the largest hedge funds holding C4 Therapeutics’s share is Caxton Associates LP. It holds C4 Therapeutics’s shares valued at 122K.
---
C4 Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.83 (349.03% Upside)
$13.83 (349.03% Upside)
Hedge Fund Trend
Decreased
By 307.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.06%
12-Months-Change
Fundamentals
Return on Equity
-41.89%
Trailing 12-Months
Asset Growth
-23.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
C4 Therapeutics
C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
---
Top 5 ETFs holding CCCC
iShares NASDAQ US Biotechnology UCITS ETF
$77.94K
Fidelity MSCI Health Care Index ETF
$56.52K
Invesco Nasdaq Biotechnology ETF
$2.98K
Up to five ETFs with an Outperform Smart Score that hold CCCC. The ETFs are listed according to market value of CCCC within the ETF
---
Aura Biosciences Inc
―
Biohaven Ltd.
―
Nkarta
―
Scholar Rock Holding
―
Atara Biotherapeutics
―
---